Catalyst Wire Dossier Catalyst Wire Dossier

rhPTH Therapy

recombinant human parathyroid hormone
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rhPTH Therapy, covering 2016-01-12 to 2016-01-12. Get the full timeline:

Most recent: Clinical Trial Update: rhPTH Therapy for Low Turnover Bone Fragility [Phase 1]

See pricing